- Home
- ANVS vs LOAN Comparison
ANVS vs LOAN Comparison
Compare ANVS & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | LOAN |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 47.6M |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ANVS | LOAN |
|---|---|---|
| Price | $0.99 | $3.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.50 | N/A |
| AVG Volume (30 Days) | ★ 715.8K | 47.0K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 12.87% |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $8,666,307.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $3.31 |
| 52 Week High | $5.50 | $5.27 |
Technical Indicators
Market Signals| Indicator | ANVS | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 35.65 | 29.45 |
| Support Level | N/A | $3.31 |
| Resistance Level | $1.43 | $4.52 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 20.69 | 6.24 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.